Cargando…
Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085663/ https://www.ncbi.nlm.nih.gov/pubmed/35174429 http://dx.doi.org/10.1007/s11307-022-01709-1 |
_version_ | 1784703867238219776 |
---|---|
author | Friberger, Ida Jussing, Emma Han, Jinming Goos, Jeroen A. C. M. Siikanen, Jonathan Kaipe, Helen Lambert, Mélanie Harris, Robert A. Samén, Erik Carlsten, Mattias Holmin, Staffan Tran, Thuy A. |
author_facet | Friberger, Ida Jussing, Emma Han, Jinming Goos, Jeroen A. C. M. Siikanen, Jonathan Kaipe, Helen Lambert, Mélanie Harris, Robert A. Samén, Erik Carlsten, Mattias Holmin, Staffan Tran, Thuy A. |
author_sort | Friberger, Ida |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9085663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-90856632022-05-11 Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications Friberger, Ida Jussing, Emma Han, Jinming Goos, Jeroen A. C. M. Siikanen, Jonathan Kaipe, Helen Lambert, Mélanie Harris, Robert A. Samén, Erik Carlsten, Mattias Holmin, Staffan Tran, Thuy A. Mol Imaging Biol Correction Springer International Publishing 2022-02-16 2022 /pmc/articles/PMC9085663/ /pubmed/35174429 http://dx.doi.org/10.1007/s11307-022-01709-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Friberger, Ida Jussing, Emma Han, Jinming Goos, Jeroen A. C. M. Siikanen, Jonathan Kaipe, Helen Lambert, Mélanie Harris, Robert A. Samén, Erik Carlsten, Mattias Holmin, Staffan Tran, Thuy A. Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title | Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_full | Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_fullStr | Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_full_unstemmed | Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_short | Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_sort | correction: optimisation of the synthesis and cell labelling conditions for [89zr]zr-oxine and [89zr]zr-dfo-ncs: a direct in vitro comparison in cell types with distinct therapeutic applications |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085663/ https://www.ncbi.nlm.nih.gov/pubmed/35174429 http://dx.doi.org/10.1007/s11307-022-01709-1 |
work_keys_str_mv | AT fribergerida correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT jussingemma correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT hanjinming correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT goosjeroenacm correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT siikanenjonathan correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT kaipehelen correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT lambertmelanie correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT harrisroberta correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT samenerik correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT carlstenmattias correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT holminstaffan correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT tranthuya correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications |